Clinical trials
Breast - Female clinical trials
Below are recruiting breast - female clinical trials, each written for real people, not researchers. We’re tracking 3,704 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07578103Recruiting
Dairy vs Plant-based Yogurt for Weight and Bone Health
This study compares how dairy yogurt and plant-based yogurt affect weight, body composition, bone strength, and gut bacteria in postmenopausal women. It may help identify which type of yogurt is better for overall health during this life stage.
Québec, QuebecAges 40 years+ - NCT07527741Recruiting
HER2-Positive Breast Cancer Treatment Patterns Study
This study tracks how patients with HER2-positive early-stage breast cancer receive treatment and stick to their treatment plan after their care moves to local hospitals. The trial helps doctors understand whether patients follow through with their recommended therapy when treated closer to home.
Loznica, Bolnička 65Ages 18 years+ - NCT07528963Enrolling by invitation
Enhanced Cancer Survivorship Care in Rural Kansas Clinics
This study tests a new model of cancer care designed for rural areas, focusing on helping breast, prostate, lung, and colorectal cancer survivors manage their health after treatment. The study works through primary care clinics to make survivorship care more accessible and effective.
Kansas City, KansasAges 18–75 - NCT07462611Recruiting
Starting PrEP for HIV prevention in the emergency department
This study is testing whether starting PrEP (daily pills to prevent HIV) right away in the emergency department helps people at high risk for HIV. It aims to make it easier to start protection before you leave the hospital.
Dallas, TexasAges 18 years+ - NCT07387419Recruiting
Steroid Hormone Rhythms in Adrenal Nodules
This study looks at how your body's natural steroid rhythms change when you have adrenal nodules. It compares people with non-secreting nodules to those with a mild hormone excess (MACS) to see if there are differences in daily cortisol patterns.
PessacAges 18 years+ - NCT07410949Recruiting
Acupressure education after birth and breastfeeding success
This study tests whether teaching new mothers acupressure can improve their breastfeeding experience. If you have had a healthy single baby, plan to breastfeed, and are within the first two days after delivery, you may be able to join.
Niğde, MerkezAges 18–45 - NCT07327840RecruitingPhase 2
Study of Kylo-11 for heart disease with high Lp(a)
This trial tests a new drug, Kylo-11, for people with heart or blood vessel disease and high Lp(a), a type of cholesterol that raises risk of heart problems. The study will see if Kylo-11 can help lower that risk.
Los Angeles, CaliforniaAges 18–80 - NCT07315646Recruiting
Pain from IUD insertion: traditional vs. ultrasound-guided
This study tests if using ultrasound during IUD (intrauterine system) insertion reduces pain compared to the standard method. If you are getting a Kyleena or Mirena IUD, your experience may help improve comfort for other women.
GhentAges 18–60 - NCT07203053RecruitingPhase 2
Tarlatamab for advanced small cell lung cancer after first treatment
This trial tests a new drug called tarlatamab for people with advanced small cell lung cancer that has worsened after one prior round of chemotherapy plus immunotherapy. It's designed for patients who are still active but may need extra support (ECOG 2).
AngersAges 18 years+ - NCT07233993Recruiting
Ultrasound-guided vs. standard Botox injections for cervical dystonia
This trial compares using ultrasound to guide Botox injections versus the usual method without ultrasound, to see if it improves outcomes for people with cervical dystonia.
MilanAges 18 years+ - NCT07260968Recruiting
Better Pumping Workflows to Help Breastfeeding Parents
This study tests a better way to help parents pump breast milk more efficiently. It also looks at how the body makes milk. It may help you breastfeed longer and with less hassle.
Rochester, New YorkAges 18–45 - NCT07264673RecruitingPhase 2
Cemiplimab plus OSE2101 as maintenance after chemo-immunotherapy for lung cancer
This trial tests a combination of two drugs (cemiplimab and OSE2101) as ongoing treatment after initial chemo-immunotherapy for advanced lung cancer. It is for patients whose tumor DNA is still detectable in the blood, and who carry a specific immune marker called HLA-A2.
Roma, RMAges 18–99 - NCT07179887Recruiting
Arm cuff treatment for better brain blood flow in older adults
This trial tests if a simple, at-home arm cuff treatment (Remote Ischaemic Conditioning) can improve blood flow regulation in the brain of older adults. It may help understand how to protect brain health as we age.
Derby, DerbyshireAges 65–85 - NCT07145567Recruiting
Study of small blood vessel disease in type 1 diabetes
This study looks at small blood vessel disease (microangiopathy) in people with type 1 diabetes. It will use special devices to examine your skin and blood vessels to understand how diabetes affects them.
Danderyd, Stockholm CountyAges 18–60 - NCT07087574Recruiting
Study of 3D printed tools for eating independence in rehab
This study tests whether using 3D printed tools can help people with neurodegenerative diseases eat more independently during their hospital stay. It focuses on patients who already need some help with meals, and aims to see if custom-made utensils or aids can give them more autonomy.
Hyères, VarAges 18 years+ - NCT00114647Recruiting
Blood draw to collect plasma or white blood cells for lab tests
This trial uses a special blood-removal procedure called apheresis to collect either plasma or white blood cells for laboratory research. It may help scientists understand infection or immune-related processes by providing specific blood components for study.
Bethesda, MarylandAges 18–100 - NCT06465069RecruitingPhase 1
Study of a new drug for advanced bladder and other solid tumors
This study tests a new drug (LY4052031) for people with several types of advanced solid tumors, especially bladder cancer. It aims to see if the drug is safe and effective when given alone or after other treatments have stopped working.
Duarte, CaliforniaAges 18 years+ - NCT07595458RecruitingPhase 1
Safety Study of JST-018 Immune Treatment in Healthy Adults
This is a first-in-human safety study testing a new experimental immune therapy called JST-018. Researchers want to see how safe it is, how well your body tolerates it, and how your body processes it when given as an injection.
Las Vegas, NevadaAges 18–55 - NCT05507879Recruiting
Breast cancer heart monitoring to predict heart damage risk
This trial studies how a blood test marker (TRPC6) may help predict and prevent heart muscle damage and heart failure related to some breast cancer medicines. You may join if you’re starting or have received treatment that can stress the heart, or if you already have signs of treatment-related heart problems.
Gainesville, FloridaAges 18 years+ - NCT05334069Recruiting
Blood test study for early cancer detection in patients
This study collects blood from people with cancer and people without cancer (or with possible cancer) to test whether new blood tests can detect cancer earlier. Your blood samples help researchers evaluate how well these tests work.
Anchorage, AlaskaAges 40–75 - NCT07566494RecruitingPhase 1
Testing VAS-101 for sickle cell disease
This early-phase trial tests a new drug called VAS-101 for people with sickle cell disease. It aims to find a safe dose and see how the drug affects the body.
Bethesda, MarylandAges 18–90 - NCT06658912Recruiting
Weight loss program for breast cancer survivors
This study tests a weight loss program designed specifically for women who have finished breast cancer treatment. It aims to help improve overall health after cancer.
Durham, North CarolinaAges 21–90 - NCT06106477Recruiting
Intermittent fasting for women with early breast cancer
This trial studies whether a 14-hour night fast and 10-hour eating window can improve inflammation markers and quality of life in women with HR+/HER2- early breast cancer. You would start the fasting routine within three months of beginning hormone therapy.
Milwaukee, WisconsinAges 18 years+ - NCT07580105Recruiting
AI tool to help diagnose breast cancer from MRI scans
This study tests a new artificial intelligence software called Kenko Breast AI+ that analyzes breast MRI scans to help doctors better detect and monitor breast cancer. If you've had or are planning to have a breast MRI for cancer concerns, this trial might be right for you.
Elche, AlicanteAges 18 years+
Hear when a new Breast - Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for breast - female?
- Yes. Clin2 currently lists 3,704 recruiting breast - female studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a breast - female trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a breast - female trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.